William Blair Downgrades Evommune to Market Perform

Benzinga Newsdesk www.benzinga.com Negative 90.2%

Neg 90.2% Neu 0% Pos 0%

William Blair analyst Matt Phipps downgrades Evommune (NYSE:EVMN) from Outperform to Market Perform.

Comments

No comments yet. Be the first!